Categories | Inventors

T2* Mapping for quantitative assessment of placental function and oxygenation


OHSU # 1991

Technology Overview:

Despite recent focus, including the announcement of the NIH Human Placenta Project, on placental health and function as a primary driver of fetal growth and development, current in vivo identification and assessment of abnormal placentation is limited. This MRI protocol and modeling methodology, which uses an endogeneous contrast agent and therefore is non-invasive, facilitates assessment of oxygenation and blood flow in the placenta. This technique could be used in pregnancies complicated by preeclampsia, preterm labor, intrauterine growth restriction, diabetes mellitus, chronic hypertension and other high risk conditions associated with abnormal placentation.



PublishedUnited StatesWO 2017/053799
PublishedUnited StatesUS2017/0086720

Other Patents Filed


For more information, contact:

Trina Voss
Technology Development Manager